Prognostic Value of Combined Detection of Serum IL6, YKL-40, and C-reactive Protein in Patients with Unresectable Pancreatic Cancer

Inna M Chen, Astrid Z Johansen, Christian Dehlendorff, Benny V Jensen, Stig E Bojesen, Per Pfeiffer, Jon K Bjerregaard, Svend Erik Nielsen, Fahimeh Andersen, Niels H Holländer, Mette Yilmaz, Louise S Rasmussen, Julia S Johansen

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

OriginalsprogEngelsk
TidsskriftCancer Epidemiology, Biomarkers & Prevention
Vol/bind29
Udgave nummer1
Sider (fra-til)176-184
Antal sider9
ISSN1055-9965
DOI
StatusUdgivet - jan. 2020

Fingeraftryk Dyk ned i forskningsemnerne om 'Prognostic Value of Combined Detection of Serum IL6, YKL-40, and C-reactive Protein in Patients with Unresectable Pancreatic Cancer'. Sammen danner de et unikt fingeraftryk.

  • Citationsformater

    Chen, I. M., Johansen, A. Z., Dehlendorff, C., Jensen, B. V., Bojesen, S. E., Pfeiffer, P., Bjerregaard, J. K., Nielsen, S. E., Andersen, F., Holländer, N. H., Yilmaz, M., Rasmussen, L. S., & Johansen, J. S. (2020). Prognostic Value of Combined Detection of Serum IL6, YKL-40, and C-reactive Protein in Patients with Unresectable Pancreatic Cancer. Cancer Epidemiology, Biomarkers & Prevention, 29(1), 176-184. https://doi.org/10.1158/1055-9965.EPI-19-0672